US 10668170
Modified RNAi agents
granted A61KA61K48/00A61P
Quick answer
US patent 10668170 (Modified RNAi agents) held by Alnylam Pharmaceuticals, Inc. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K48/00, A61P, A61P31/12, A61P31/18